[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 27, Issue 3 (9-2019) ::
sjimu 2019, 27(3): 173-182 Back to browse issues page
Comparison of Serum Level and IL-18 Gene Expression and Reactive Protein in Patients with Type 2 Diabetes with Metabolic Syndrome and Healthy People
Leila Yadolahi Farsani1 , Noosha Zia-jahromi 2, Mohammad Vaezipour3
1- Dept of Basic Science, Faculty of Biology, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
2- Dept of Basic Science, Faculty of Biology, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran , nooshazia.59@gmail.com
3- Faculty of Medical Sciences, Shahid Beheshti University, Tehran, Iran
Abstract:   (921 Views)
Introduction: Metabolic syndrome is a common clinical anomaly, with an increased risk of developing type 2 diabetes and cardiovascular risk factors. Increased inflammatory mediators, such as reactive protein,as well as the inflammatory cytokines can be associated with the incidence and progression of metaboli syndrome and type 2 diabetes.
 
Materials & Methods: This study was performed on 35 male and female patients with an average age of 55 years, type 2 diabetes mellitus with metabolic syndrome and 35 healthy subjects as control group. Separated serum samples were kept at -20 ° C for quantitative evaluation of serum IL-18 by ELISA kit and C-reactive protein. RNA extraction from cells was performed by JenaBioscience kit and finally Gene expression assay was performed quantitatively using Real Time RTPCR.
 
Findings: The mean serum levels of IL-18 were significantly increased (P=0.008), and serum reactive protein (P<0.001) was significantly increased in patients with type 2 diabetes mellitus with metabolic syndrome compared with healthy subjects. Also, expression of IL-18 gene (P=0.003) in lymphocyte cells of type II diabetes patients with metabolic syndrome was significantly higher than healthy subjects.
 
Discussion & Conclusions: The present study showed that patients with type 2 diabetes mellitus with metabolic syndrome have high levels of inflammatory factors such as IL-18 in their serum. it can be concluded that serum levels of IL-18, C-reactive protein and IL-18 expression play an important role in inflammatory response and progression. Type 2 diabetes and metabolic syndrome.
Keywords: Interleukin 18, C-reactive protein, Type II diabetes, Metabolic syndrome
Full-Text [PDF 722 kb]   (276 Downloads)    
Type of Study: Research | Subject: biology
Received: 2018/08/6 | Accepted: 2019/01/20 | Published: 2019/09/15
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yadolahi Farsani L, Zia-jahromi N, Vaezipour M. Comparison of Serum Level and IL-18 Gene Expression and Reactive Protein in Patients with Type 2 Diabetes with Metabolic Syndrome and Healthy People . sjimu. 2019; 27 (3) :173-182
URL: http://sjimu.medilam.ac.ir/article-1-5113-en.html


Volume 27, Issue 3 (9-2019) Back to browse issues page
مجله علمی پزوهشی دانشگاه علوم پزشکی ایلام scientific journal of ilam university of medical sciences
Persian site map - English site map - Created in 0.18 seconds with 31 queries by YEKTAWEB 4227